MAP2 and Alzheimer disease: Conversely, for the NT-TBI group (36.25±3.92 neurons/HPF) there was no significant difference in MAP2 positive cells when compared to the AD-Sham group (p>0.05) and NT-Sham group (p>0.05) (Figure 5B).